Influence of pore size and surface area of mesoporous silica materilas (MCM-41 and KIT-6) on the drug loading and release
- 136 Downloads
Mesoporous silica KIT-6 and MCM-41 with different pore sizes has been prepared through the sol–gel and hydrothermal method, respectively. The synthesized mesoporous materials were modified by a chemical modification using 3-aminopropyl triethoxysilane (APTES) to obtain KIT-6-NH2 and MCM-41-NH2 as drug delivery carriers. The mesostructure properties was fully characterized by scanning electron microscope (SEM), N2 sorption isotherm, Fourier transform infrared (FT-IR), X-ray diffraction (XRD). Loading of resveratrol (RSV) drug as a model into synthesized mesoporous carriers and amine functionalized forms were studied using thermogravimetric analysis (TGA) and UV–visible spectroscopy (UV–Vis). The loading uptake and release behavior of RSV was highly dependent on the textural properties (such as pore size and surface area) of mesoporous silica and modified carriers. The release of drugs was carefully studied in different pH. The effect of the synthesized carriers and RSV@mesoporous drug carriers on MCF-7 human breast cancer cell line viability was evaluated. Both carriers alone revealed no toxicity to MCF-7 cancer cells. But, RSV@carriers or RSV@modified carriers indicated an inhibition of cell livability, when compared to the non-encapsulated drug. RSV@modified mesoporous carriers demonstrated cell viability inhibition better than RSV@mesoporous carriers. The inhibition of cell viability of RSV@modified mesoporous carriers depends on surface area and functionalized groups of carriers more than pore size. First order, Higuchi, HixsoneCrowell and KorsmeyerePeppas release kinetic models were applied to the experimental data and the release was found to obey a first-order rate kinetic.
The Resveratrol (RSV) is an experimental anticancer drug.
MCM-41 and KIT-6 were used as carriers for encapsulation of RSV drug.
The loading and release of RSV depends on surface area and pore size of carriers.
Amino groups play an important role in increased drug loading and release rate.
The effect of RSV@carriers was evaluated on MCF-7 human breast cancer.
KeywordsResveratrol Controlled release Drug carriers Breast cancer cell KIT-6-NH2
The authors are thankful to the post-graduate office of Guilan University for the support of this work.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
- 1.Wise DL (2000) Handbook of Pharmaceutical Controlled Release. Technology, 1st edn. Marcel Dekker Inc., New YorkGoogle Scholar
- 21.Sanjini NS, Velmathi S (2013) Synthesis of gallium doped mesoporous KIT-6 for the photocatalytic degradation of dye. Asian J Chem 25:S69–S72Google Scholar
- 23.Fazaeli R, Aliyan H, Foroushani SP, Mohagheghian Z, Heidari Z (2013) Mesoporous silica KIT-6 Heterogeneous catalysis Polyoxotungstate. Iran J Catal 3:129–137Google Scholar
- 44.Gerweck LE, Seetharaman K (1996) Cellular pH gradient in tumor versus normal tissue: potential exploitation for the treatment of cancer. Cancer Res 56:1194–1198Google Scholar